Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 111
Filtrar
Más filtros

Tipo del documento
Intervalo de año de publicación
1.
Environ Sci Technol ; 56(12): 7883-7894, 2022 06 21.
Artículo en Inglés | MEDLINE | ID: mdl-35593893

RESUMEN

Antibiotics could enter farmlands through sewage irrigation or manure application, causing combined pollution with pesticides. Antibiotics may affect the environmental fate of pesticides and even increase their bioavailability. In this study, the influence of monensin on the degradation, toxicity, and availability of atrazine in soil-earthworm microcosms was investigated. Monensin inhibited the degradation of atrazine, changed the metabolite patterns in soil, and increased the bioavailability of atrazine in earthworms. Atrazine and monensin had a significant synergistic effect on earthworms in the acute toxic test. In long-term toxicity tests, co-exposure of atrazine and monensin also led to worse effects on earthworms including oxidative stress, energy metabolism disruption, and cocoon production compared to single exposure. The expression of tight junction proteins was down-regulated significantly by monensin, indicating that the intestinal barrier of earthworms was weakened, possibly causing the increased bioavailability of atrazine. The expressions of heat shock protein 70 (Hsp70) and reproductive and ontogenetic factors (ANN, TCTP) were all downregulated in binary exposure, indicating that the resilience and cocoon production of earthworms were further weakened under combined pollution. Monensin disturbed the energy metabolism and weakened the intestinal barrier of earthworms. These results showed that monensin increased the risks of atrazine in agricultural areas.


Asunto(s)
Atrazina , Oligoquetos , Plaguicidas , Contaminantes del Suelo , Animales , Antibacterianos/farmacología , Atrazina/toxicidad , Monensina/farmacología , Monensina/toxicidad , Plaguicidas/metabolismo , Suelo , Contaminantes del Suelo/metabolismo
2.
Ecotoxicol Environ Saf ; 245: 114110, 2022 Oct 15.
Artículo en Inglés | MEDLINE | ID: mdl-36155339

RESUMEN

Antibiotic residue has become an emerging environmental contaminant, while the toxicological effects and underlying mechanisms caused by the co-exposure to multiple veterinary antibiotics were rarely studied. In this study, male Sprague Dawley rats were exposed to monensin (M) (1, 2, 10 mg/(kg·body weight (BW)) combined with sulfamethazine (S) (60, 120, 600 mg/(kg·BW)) or single drugs for 28 consecutive days. The body weight, hematological and blood biochemical parameters, organ coefficients, and histopathology were analyzed to discover their combined toxicity effect. Transcriptomic analysis was used to reveal the possible mechanisms of their joint toxicity. Compared with the control group, the weight gain rate was significantly reduced in the H-M+S and H-S, and alkaline phosphatase in H-M+S was significantly increased. Furthermore, relative liver and kidneys weight was significantly increased, and the liver of H-M+S showed more severe lesions in histopathological analysis. For H-M+S, H-M and H-S, transcriptomic results showed that 344, 246, and 99 genes were differentially expressed, respectively. The Gene Ontology terms mainly differ in sterol biosynthetic process and steroid hydroxylase activity. The Kyoto Encyclopedia of Genes and Genome pathways showed abnormal retinol metabolism, metabolism of xenobiotics by cytochrome P450, and drug metabolism-cytochrome 450; the common 30 genes were screened from the network of protein-protein interaction. The results showed that mixed contamination of M and S produces hepatotoxicity by interfering with linoleic acid metabolism, retinol metabolism and CYP450 enzyme-dominated drug metabolism. Further analysis showed that Cyp1a2, Cyp2c61, Ugt1a3, and Ugt1a5 might be the key genes. These findings could provide more evidence for investigating the toxic effects and metabolism of mixed antibiotics contamination in mammals.


Asunto(s)
Monensina , Sulfametazina , Fosfatasa Alcalina/metabolismo , Animales , Antibacterianos/farmacología , Peso Corporal , Citocromo P-450 CYP1A2/metabolismo , Sistema Enzimático del Citocromo P-450/genética , Sistema Enzimático del Citocromo P-450/metabolismo , Ácido Linoleico , Hígado , Masculino , Mamíferos/metabolismo , Monensina/toxicidad , Ratas , Ratas Sprague-Dawley , Esteroide Hidroxilasas/metabolismo , Esteroide Hidroxilasas/farmacología , Esteroles/metabolismo , Esteroles/farmacología , Sulfametazina/toxicidad , Transcriptoma , Vitamina A/metabolismo , Xenobióticos/metabolismo
3.
J Environ Sci Health B ; 55(2): 127-134, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-31588829

RESUMEN

Monensin (MON) is a coccidiostat used as a growth promoter that can reach the environment through fertilization with manure from farm animals. To verify whether field-relevant concentrations of this drug negatively influence the structure and activity of tropical soil bacteria, plate counts, CO2 efflux measurements, phospholipid fatty acids (PLFA) and community-level physiological profiling (CLPP) profiles were obtained for soil microcosms exposed to 1 or 10 mg kg-1 of MON across 11 days. Although 53% (1 mg kg-1) to 40% (10 mg kg-1) of the MON concentrations added to the microcosms dissipated within 5 days, a subtle concentration-dependent decrease in the number of culturable bacteria (<1 log CFU g-1), reduced (-20 to -30%) or exacerbated (+25%) soil CO2 effluxes, a marked shift of non-bacterial fatty acids, and altered respiration of amines (1.22-fold decrease) and polymers (1.70-fold increase) were noted in some of the treatments. These results suggest that MON quickly killed some microorganisms and that the surviving populations were selected and metabolically stimulated. Consequently, MON should be monitored in agronomic and environmental systems as part of One Health efforts.


Asunto(s)
Consorcios Microbianos/efectos de los fármacos , Monensina/toxicidad , Microbiología del Suelo , Contaminantes del Suelo/toxicidad , Drogas Veterinarias/toxicidad , Bacterias/efectos de los fármacos , Bacterias/metabolismo , Dióxido de Carbono/metabolismo , Costa Rica , Relación Dosis-Respuesta a Droga , Ácidos Grasos/metabolismo , Ionóforos/toxicidad , Fosfolípidos/metabolismo
4.
Drug Chem Toxicol ; 37(4): 384-90, 2014 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-24341700

RESUMEN

OBJECTIVE: The present study was undertaken to explore the effects of monensin, a potent Golgi disturbing agent on male fertility. METHODS: Male Wistar rats were administered monensin at the dose levels of 2.5, 5, and 10 mg/kg b wt. Animals were sacrificed after 67 days of the treatment. The activities of lactate dehydrogenase (LDH), ATPase, acid phosphatase and thiamine pyrophosphatase (TPPase) were measured in the testis. Cytochemical assay of Golgi body marker enzyme, thiamine pyrophosphatase was also performed. Ultrastructural changes in testis were studied by Transmission electron microscopy. Sperm number and motility were also examined. RESULTS AND DISCUSSION: The alterations in the activities of above mentioned enzymes indicate the pronounced effect of the drug on the functioning of spermatogenic cells. The findings from electron microscopy such as membrane disruption, swelling and disintegration of Golgi apparatus strongly suggest the interference of monensin with the functioning of Golgi apparatus in the spermatogenic cells. Data from the sperm number and motility as well as the fertility studies and the resulted litter size further points towards the antifertility effects of monensin in male rats. CONCLUSION: The findings from the present study strongly indicated the effects of monensin on the testis, involving alterations in key enzyme activities and changes at the ultrastructural level.


Asunto(s)
Aparato de Golgi/efectos de los fármacos , Monensina/toxicidad , Motilidad Espermática/efectos de los fármacos , Testículo/efectos de los fármacos , Animales , Relación Dosis-Respuesta a Droga , Fertilidad/efectos de los fármacos , Aparato de Golgi/patología , Masculino , Microscopía Electrónica de Transmisión , Monensina/administración & dosificación , Ratas , Ratas Wistar , Recuento de Espermatozoides , Espermatogénesis/efectos de los fármacos , Testículo/patología , Testículo/ultraestructura , Tiamina Pirofosfatasa/metabolismo
5.
Environ Toxicol Pharmacol ; 108: 104454, 2024 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-38670417

RESUMEN

Monensin, an antibacterial commonly used in animal fattening, can enter aquatic ecosystems and harm non-target organisms. Since there are no previous studies about the effects of monensin on amphibians, the aim of the present study was to evaluate the lethal and sublethal toxicity of a commercial formulation of monensin (CFM) through standardized bioassays with embryos and larvae of the amphibian Rhinella arenarum. Oxidative stress (catalase and glutathione S-transferase activities, and reduced glutathione and lipid peroxidation levels), cholinesterasic effect (acetylcholinesterase and butyrylcholinesterase activities) and mutagenicity (micronuclei frequency) biomarkers were evaluated. The CFM produced teratogenic effects, with a teratogenic index of 6.21. Embryos (504 h-LC50: 273.33 µg/L) were more sensitive than larvae, as no significant mortality was observed on larvae exposed up to 3000 µg/L for 504 h. However, oxidative stress, cholinesterasic effect and mutagenicity biomarkers were altered on larvae exposed for 96 h to environmentally relevant concentrations (4, 12 and 20 µg/L of monensin active ingredient). The CFM caused adverse effects on the exposed organisms, primarily on embryos, leading to lethal and sublethal effects, which could impact the wildlife when it reaches aquatic ecosystems.


Asunto(s)
Embrión no Mamífero , Larva , Monensina , Estrés Oxidativo , Contaminantes Químicos del Agua , Animales , Larva/efectos de los fármacos , Monensina/toxicidad , Embrión no Mamífero/efectos de los fármacos , Estrés Oxidativo/efectos de los fármacos , Contaminantes Químicos del Agua/toxicidad , Acetilcolinesterasa/metabolismo , Teratógenos/toxicidad , Peroxidación de Lípido/efectos de los fármacos , Bufo arenarum , Butirilcolinesterasa/metabolismo , Glutatión Transferasa/metabolismo
6.
Toxins (Basel) ; 14(7)2022 06 30.
Artículo en Inglés | MEDLINE | ID: mdl-35878184

RESUMEN

Carboxylic ionophores, such as monensin, salinomycin and lasalocid, are polyether antibiotics used widely in production animals for the control of coccidiosis, as well as for the promotion of growth and feed efficiency. Although the benefits of using ionophores are undisputed, cases of ionophore toxicosis do occur, primarily targeting the cardiac and skeletal muscles of affected animals. The 3-[4,5-dimethylthiazol-2yl]-2,5-diphenyl tetrazolium bromide (MTT) viability assay was used to determine the cytotoxicity of monensin, salinomycin and lasalocid on mouse skeletal myoblasts (C2C12). Immunocytochemistry and immunofluorescent techniques were, in turn, performed to investigate the effects of the ionophores on the microfilament, microtubule and intermediate filament, i.e., desmin and synemin networks of the myoblasts. Monensin was the most cytotoxic of the three ionophores, followed by salinomycin and finally lasalocid. Monensin and salinomycin exposure resulted in the aggregation of desmin around the nuclei of affected myoblasts. The synemin, microtubule and microfilament networks were less affected; however, vesicles throughout the myoblast's cytoplasm produced gaps within the microtubule and, to a limited extent, the synemin and microfilament networks. In conclusion, ionophore exposure disrupted desmin filaments, which could contribute to the myofibrillar degeneration and necrosis seen in the skeletal muscles of animals suffering from ionophore toxicosis.


Asunto(s)
Lasalocido , Monensina , Animales , Proteínas del Citoesqueleto , Desmina , Ionóforos/toxicidad , Ratones , Monensina/toxicidad , Mioblastos , Piranos
7.
Avian Dis ; 55(3): 516-21, 2011 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-22017059

RESUMEN

Peracute onset of disease was reported in a 42-wk-old broiler breeder flock that was presented by error with feed containing monensin at approximately seven times the approved level for broiler chickens. Morbidity and mortality were extremely high, and the affected chickens displayed feed refusal, decreased water consumption, and severe paralysis that ranged from abnormal gait to a complete inability to move. During the first 10 days postingestion of the suspect feed, mortality in hens reached 13.7% and 70.9% in the roosters. Hen day production decreased from 67% to 3% in the same period of time. A total of 638 g/ton of monensin was detected in suspect feed samples by one laboratory and 740 g/ton in a second laboratory. Twenty-one days after removal of the suspect feed, the mortality rate returned to normal levels in both hens and roosters, albeit feed consumption and egg production remained extremely low, which prompted the company involved to eliminate the flock.


Asunto(s)
Alimentación Animal/microbiología , Pollos , Monensina/toxicidad , Enfermedades de las Aves de Corral/diagnóstico , Enfermedades de las Aves de Corral/epidemiología , Animales , Deshidratación/diagnóstico , Deshidratación/epidemiología , Deshidratación/microbiología , Deshidratación/patología , Femenino , Masculino , Músculo Esquelético/patología , Miocardio/patología , Oviposición , Parálisis/diagnóstico , Parálisis/epidemiología , Parálisis/microbiología , Parálisis/patología , Enfermedades de las Aves de Corral/microbiología , Enfermedades de las Aves de Corral/patología , Streptomyces/patogenicidad , Estados Unidos/epidemiología
8.
Am J Vet Res ; 71(1): 55-9, 2010 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-20043781

RESUMEN

OBJECTIVE: To compare cardiac troponin I (cTnI) concentrations determined by use of a point-of-care analyzer with values determined by use of a bench-top immunoassay in plasma samples obtained from clinically normal horses with and without experimentally induced cardiac disease, and to establish a reference range for plasma equine cTnI concentration determined by use of the point-of-care analyzer. ANIMALS: 83 clinically normal horses, 6 of which were administered monensin to induce cardiac disease. PROCEDURES: A blood sample was collected from each of the 83 clinically normal horses to provide plasma for analysis by use of the point-of-care analyzer; some of the same samples were also analyzed by use of the immunoassay. All 83 samples were used to establish an analyzer-specific reference range for plasma cTnI concentration in clinically normal horses. In 6 horses, blood samples were also collected at various time points after administration of a single dose of monensin (1.0 to 1.5 mg/kg) via nasogastric intubation; plasma cTnI concentration in those samples was assessed by use of both methods. RESULTS: The analyzer-specific reference range for plasma cTnI concentration in clinically normal horses was 0.0 to 0.06 ng/mL. Following monensin treatment in 5 horses, increases in plasma cTnI concentration determined by use of the 2 methods were highly correlated (Pearson correlation, 0.83). Peak analyzer-determined plasma cTnI concentrations in monensin-treated horses ranged from 0.08 to 3.68 ng/mL. CONCLUSIONS AND CLINICAL RELEVANCE: In horses with and without experimentally induced cardiac disease, the point-of-care analyzer and bench-top immunoassay provided similar values of plasma cTnI concentration.


Asunto(s)
Cardiopatías/veterinaria , Enfermedades de los Caballos/sangre , Sistemas de Atención de Punto , Troponina I/sangre , Animales , Femenino , Cardiopatías/sangre , Cardiopatías/inducido químicamente , Caballos , Ionóforos/toxicidad , Masculino , Monensina/toxicidad
9.
Equine Vet J ; 52(6): 848-856, 2020 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-32145094

RESUMEN

BACKGROUND: Monensin is highly toxic to horses and inadvertent ingestion can result in cardiac injury and death. OBJECTIVES: To describe sequelae of monensin ingestion and to determine clinical predictors of outcome. STUDY DESIGN: Observational clinical study. METHODS: Physical examination, electrocardiogram and echocardiography were performed on 76 horses accidentally exposed to monensin-contaminated feed. Four horses were examined within 14 days of exposure (acute period), 29 horses were examined between 15 and 45 days post-exposure (subacute period) and 70 horses were examined 4-10 months after exposure (chronic period). Follow-up information was obtained for 56 horses by telephone interviews approximately 16 months after exposure. RESULTS: Cardiac abnormalities were detected in 4/4, 19/29 and 31/70 horses during the acute, subacute and chronic periods, respectively. Sixteen months post-exposure, 34 of the 64 horses (53%) for which the outcome was known had returned to their previous use, 13 (20%) were reported to be exercise intolerant, three (5%) were retired and 14 (22%) were dead (two deaths, 12 euthanasia). Thinning of the myocardium observed at any point in time was associated with a negative outcome. Heterogeneity of the myocardium observed in the acute/subacute period was associated with a negative outcome while subjective contractile intraventricular dyssynchrony, cardiac chamber dilation, decreased fractional shortening and multiple premature ventricular complexes observed in the chronic period were associated with a negative outcome. Some horses with significant changes associated with a negative outcome in the chronic phase still returned to their previous work. MAIN LIMITATIONS: No control group and only 27 horses were examined more than once. CONCLUSIONS: Clinical outcome of horses exposed to sublethal doses of monensin is highly variable. The presence of heterogeneity and thinning of the myocardium shortly after intoxication were associated with a negative outcome.


Asunto(s)
Enfermedades de los Caballos/inducido químicamente , Monensina/efectos adversos , Monensina/toxicidad , Animales , Ecocardiografía/veterinaria , Electrocardiografía , Caballos , Miocardio
10.
J Vet Diagn Invest ; 21(3): 338-43, 2009 May.
Artículo en Inglés | MEDLINE | ID: mdl-19407085

RESUMEN

Six adult horses were administered sodium monensin, 1.0-1.5 mg/kg, via gastric gavage. Anorexia and/or diarrhea occurred within 24 hr after monensin administration in all 6 horses. Cardiac disease and dysfunction were evaluated by both elevations in heart rate, echocardiography, and an increase in serum concentrations of cardiac troponin I (cTnI), occurred in 4 horses. The development and severity of cardiac disease was likely affected by the monensin dose, vehicle (water or corn oil) mixed with monensin, and/or whether the monensin was administered to fed or fasted horses. Initial increases in cTnI concentrations occurred between 24 and 72 hr after monensin administration. The 2 horses with the highest cTnI concentrations died or were euthanized within 5 days after monensin administration and had severe cardiac disease. One horse had increased cTnI concentrations from day 2 to day 16, but no apparent change in ventricular contractile function was evident on echocardiography. The fourth diseased horse did not return to cTnI reference intervals until day 27 after monensin administration, and the ventricular function was still abnormal just before euthanasia 9 months later. Cardiac troponin I measurements could be useful in managing farm outbreaks of accidental monensin feeding by the early identification of horses with cardiac disease.


Asunto(s)
Enfermedades de los Caballos/inducido químicamente , Monensina/toxicidad , Troponina I/sangre , Administración Oral , Animales , Anorexia/inducido químicamente , Anorexia/veterinaria , Diarrea/inducido químicamente , Diarrea/veterinaria , Insuficiencia Cardíaca/inducido químicamente , Insuficiencia Cardíaca/patología , Insuficiencia Cardíaca/veterinaria , Enfermedades de los Caballos/diagnóstico , Caballos , Monensina/administración & dosificación , Miocardio/patología
11.
Environ Pollut ; 246: 60-68, 2019 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-30529942

RESUMEN

The impact of commonly-used livestock antibiotics on soil nitrogen transformations under varying redox conditions is largely unknown. Soil column incubations were conducted using three livestock antibiotics (monensin, lincomycin and sulfamethazine) to better understand the fate of the antibiotics, their effect on nitrogen transformation, and their impact on soil microbial communities under aerobic, anoxic, and denitrifying conditions. While monensin was not recovered in the effluent, lincomycin and sulfamethazine concentrations decreased slightly during transport through the columns. Sorption, and to a limited extent degradation, are likely to be the primary processes leading to antibiotic attenuation during leaching. Antibiotics also affected microbial respiration and clearly impacted nitrogen transformation. The occurrence of the three antibiotics as a mixture, as well as the occurrence of lincomycin alone affected, by inhibiting any nitrite reduction, the denitrification process. Discontinuing antibiotics additions restored microbial denitrification. Metagenomic analysis indicated that Proteobacteria, Bacteroidetes, Actinobacteria, and Chloroflexi were the predominant phyla observed throughout the study. Results suggested that episodic occurrence of antibiotics led to a temporal change in microbial community composition in the upper portion of the columns while only transient changes occurred in the lower portion. Thus, the occurrence of high concentrations of veterinary antibiotic residues could impact nitrogen cycling in soils receiving wastewater runoff or manure applications with potential longer-term microbial community changes possible at higher antibiotic concentrations.


Asunto(s)
Antibacterianos/análisis , Antibacterianos/toxicidad , Microbiología del Suelo , Contaminantes del Suelo/análisis , Contaminantes del Suelo/toxicidad , Suelo/química , Bacterias/efectos de los fármacos , Bacterias/metabolismo , Desnitrificación/efectos de los fármacos , Lincomicina/análisis , Lincomicina/toxicidad , Monensina/análisis , Monensina/toxicidad , Sulfametazina/análisis , Sulfametazina/toxicidad
12.
Mol Cell Biol ; 25(3): 1025-40, 2005 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-15657430

RESUMEN

Mammalian cells were observed to die under conditions in which nutrients were depleted and, simultaneously, macroautophagy was inhibited either genetically (by a small interfering RNA targeting Atg5, Atg6/Beclin 1-1, Atg10, or Atg12) or pharmacologically (by 3-methyladenine, hydroxychloroquine, bafilomycin A1, or monensin). Cell death occurred through apoptosis (type 1 cell death), since it was reduced by stabilization of mitochondrial membranes (with Bcl-2 or vMIA, a cytomegalovirus-derived gene) or by caspase inhibition. Under conditions in which the fusion between lysosomes and autophagosomes was inhibited, the formation of autophagic vacuoles was enhanced at a preapoptotic stage, as indicated by accumulation of LC3-II protein, ultrastructural studies, and an increase in the acidic vacuolar compartment. Cells exhibiting a morphology reminiscent of (autophagic) type 2 cell death, however, recovered, and only cells with a disrupted mitochondrial transmembrane potential were beyond the point of no return and inexorably died even under optimal culture conditions. All together, these data indicate that autophagy may be cytoprotective, at least under conditions of nutrient depletion, and point to an important cross talk between type 1 and type 2 cell death pathways.


Asunto(s)
Adenina/análogos & derivados , Apoptosis/fisiología , Autofagia/fisiología , Lisosomas/metabolismo , Mitocondrias/metabolismo , Fagosomas/metabolismo , Adenina/toxicidad , Animales , Apoptosis/efectos de los fármacos , Proteínas Reguladoras de la Apoptosis , Autofagia/efectos de los fármacos , Proteína 5 Relacionada con la Autofagia , Beclina-1 , Inhibidores de Caspasas , Caspasas/metabolismo , Células Cultivadas , Inhibidores Enzimáticos/toxicidad , Células HeLa , Humanos , Proteínas Inmediatas-Precoces/metabolismo , Ratones , Microscopía Electrónica de Transmisión , Proteínas Asociadas a Microtúbulos/metabolismo , Monensina/toxicidad , Proteínas/metabolismo , Proteínas Proto-Oncogénicas c-bcl-2/metabolismo , ARN Interferente Pequeño/metabolismo , Proteínas Virales/metabolismo
13.
Food Chem Toxicol ; 46(11): 3528-33, 2008 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-18834916

RESUMEN

Monensin, a well known ionophore antibiotic, may cause severe damage in neuronal cells by altering Na+/K+-ATPase and Ca2+-ATPase. We investigated whether IRFI-042, a synthetic analogue of vitamin E, may block lipid peroxidation in neuronal cells and protect against monensin neurotoxicity in chicks. Monensin toxicity was induced in chicks by once-daily administration (150 mg/kg by oral gavages), for 8 days. Sham animals received a saline solution and were used as controls. All animals were randomized to receive either IRFI-042 (20 mg/kg) or its vehicle. Survival rate, brain lipid peroxidation, mRNA for neuronal and inducible nitric oxide synthases (nNOS and iNOS) and brain histological evaluations, including immunohistochemical expression of nNOS and iNOS were performed. Monensin administration decreased survival rate, induced behavioural changes, increased brain lipid peroxidation, reduced brain nNOS mRNA and immunostaining and enhanced iNOS mRNA and immunostaining in the brain in chicks. IRFI-042 significantly improved the survival rate and counteracted monensin-induced changes in chick brains. Our data suggest that monensin is responsible of neurotoxicity in chicks by inducing oxidative stress/lipid peroxidation and that IRFI-042 might represent a useful pharmacological approach to protect against the neuronal damage induced by this monovalent carboxylic ionophorous polyether antibiotic.


Asunto(s)
Benzofuranos/farmacología , Encefalopatías/inducido químicamente , Encefalopatías/prevención & control , Encéfalo/efectos de los fármacos , Peroxidación de Lípido/efectos de los fármacos , Monensina/antagonistas & inhibidores , Animales , Encéfalo/enzimología , Encéfalo/metabolismo , Encéfalo/patología , Encefalopatías/mortalidad , Pollos , Inmunohistoquímica , Masculino , Monensina/toxicidad , Óxido Nítrico Sintasa/metabolismo , Óxido Nítrico Sintasa de Tipo II/metabolismo , ARN/biosíntesis , ARN/aislamiento & purificación , Distribución Aleatoria , Tasa de Supervivencia
14.
Environ Toxicol Chem ; 37(12): 3145-3153, 2018 12.
Artículo en Inglés | MEDLINE | ID: mdl-30183095

RESUMEN

Veterinary pharmaceuticals are widely used as food additives in the poultry industry, and the unknown consequences of releasing these compounds into the environment are of concern. The purpose of the present study was to determine the direct impact of 2 veterinary pharmaceuticals (nicarbazin and monensin), commonly used in the poultry industry, on nontarget invertebrates and plant species. Ecotoxicological tests were used to evaluate the acute and chronic toxicity in earthworms (Eisenia andrei), collembolans (Folsomia candida), and 2 plant species (Brassica rapa and Triticum aestivum). Chemical analytical measurements were in good agreement with the nominal concentrations used, although some variability was seen. The results obtained showed no effects of nicarbazin at the highest nominal tested concentration of 1000 mg a.i./kg soil dry weight on any of the organisms, whereas exposure to monensin caused a concentration-specific response pattern. Species sensitivity to monensin decreased in the following rank order: B. rapa > T. aestivum > E. andrei > F. candida, with measured median effect concentrations (based on soil exposure) ranging between approximately 10 and 120 mg/kg. Our results emphasize the importance of using a test battery when assessing ecotoxicological effects by using different ecophysiological endpoints and species from different trophic levels. Environ Toxicol Chem 2018;37:3145-3153. © 2018 SETAC.


Asunto(s)
Monensina/toxicidad , Nicarbazina/toxicidad , Suelo/química , Pruebas de Toxicidad , Drogas Veterinarias/toxicidad , Animales , Artrópodos/efectos de los fármacos , Biomasa , Brassica rapa/anatomía & histología , Brassica rapa/efectos de los fármacos , Ecotoxicología , Oligoquetos/efectos de los fármacos , Plantas/efectos de los fármacos , Contaminantes del Suelo/toxicidad , Triticum/anatomía & histología , Triticum/efectos de los fármacos
15.
Environ Toxicol Chem ; 26(8): 1614-21, 2007 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-17702333

RESUMEN

Monensin and lasalocid are polyether ionophores commonly used in the beef and poultry industries for the prevention of coccidial infections and promotion of growth. These ionophores can exhibit higher toxicity than many other antibiotics; thus, evaluating their fate in the environments associated with concentrated feed operations is important. Sorption of monensin and lasalocid was measured in eight soils of varying physiochemical composition. Organic carbon-normalized sorption coefficients (log Koc) ranged from 2.1 to 3.8 for monensin and from 2.9 to 4.2 for lasalocid and were inversely correlated to equilibrium soil-solution pH. Degradation of lasalocid and monensin in two contrasting soils with and without manure amendment was measured in moist soils at 23 degrees C and 0.03 MPa moisture potential. The half-life of both compounds in the fresh nonsterile soils was less than 4 d, for which monensin degraded slightly faster than lasalocid. Fresh liquid manure amendments did not significantly alter degradation of either compound. Based on parallel 60Co-sterilized soil experiments, some abiotic degradation of monensin was apparent, whereas lasalocid only degraded in the presence of microbes. Analysis of beef-derived lagoon effluent used for irrigation confirmed that monensin can be present at low-ppb to low-ppm concentrations in the aqueous and suspended solids fractions, respectively; however, subsequent analysis of drainage water in a nearby ditch suggested that attenuation by soil after land application will greatly reduce the amount entering surface waters.


Asunto(s)
Antibacterianos/metabolismo , Ionóforos/metabolismo , Microbiología del Suelo , Contaminantes del Suelo/metabolismo , Drogas Veterinarias/metabolismo , Adsorción , Agricultura , Antibacterianos/análisis , Antibacterianos/toxicidad , Ionóforos/análisis , Ionóforos/toxicidad , Lasalocido/análisis , Lasalocido/metabolismo , Lasalocido/toxicidad , Monensina/análisis , Monensina/metabolismo , Monensina/toxicidad , Medición de Riesgo , Contaminantes del Suelo/análisis , Contaminantes del Suelo/toxicidad , Temperatura , Factores de Tiempo , Drogas Veterinarias/análisis , Drogas Veterinarias/toxicidad
16.
Vet Rec ; 190(1): 39, 2022 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-34994411
17.
Exp Toxicol Pathol ; 58(2-3): 203-8, 2006 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-16905301

RESUMEN

Monensin, a sodium specific ionophore was evaluated for its in vitro effects on rat testis by studying changes at biochemical parameters as well as at the DNA level. It was observed that monensin produced marked alterations in the activities of various enzymes associated with the testicular functions. The significant inhibition of different enzymes of oxidative defense system points toward the generation of reactive oxygen species (ROS) by monensin treatment. The significant depletion of reduced glutathione and elevation in the level of lipid peroxidation further support the above findings. The significant inhibition of the activities of lactate dehydrogenase and adenosine triphosphatase shows the interference of monensin with the normal energy supply in spermatogenesis. Moreover, the significant increase in the activities of acid phosphatase and thiamine pyrophosphatase demonstrates the interference of monensin with the Golgi-lysosomal complex of the rat testis. Induced DNA fragmentation indicates towards the impact of monensin on the DNA integrity and apoptosis. Further studies are needed to understand the important molecular mechanisms responsible for these effects.


Asunto(s)
Daño del ADN , Monensina/toxicidad , Estrés Oxidativo/efectos de los fármacos , Testículo/efectos de los fármacos , Tiamina Pirofosfatasa/metabolismo , Adenosina Trifosfatasas/metabolismo , Animales , Supervivencia Celular/efectos de los fármacos , Fragmentación del ADN/efectos de los fármacos , Glutatión Peroxidasa/metabolismo , Masculino , Ratas , Superóxido Dismutasa/metabolismo , Testículo/metabolismo , Testículo/patología
18.
Cancer Res ; 52(3): 623-30, 1992 Feb 01.
Artículo en Inglés | MEDLINE | ID: mdl-1732050

RESUMEN

The potentiation of monoclonal antibody/ligand toxin (immunotoxin) cytotoxicity by the ionophore monensin (Mo) or by human serum albumin-monensin (HSA-Mo) conjugates was investigated. Since disulfide cross-linked HSA-Mo (HSA-SPDP-Mo) is rapidly inactivated by human serum (M. Colombatti et al., Cancer Res., 50: 1385-1391, 1990), we synthesized thioether cross-linked HSA-Mo conjugates (HSA-SIA-Mo). HSA-SIA-Mo is resistant to treatment with reducing agents (e.g., glutathione, dithiothreitol) and shows potentiating activity identical to that of Mo or of HSA-SPDP-Mo, enhancing immunotoxin (IT) cytotoxicity 45-35,000-fold. Human leukemic and tumor cell lines are highly sensitive to treatment with IT in combination with Mo, HSA-SPDP-Mo, or HSA-SIA-Mo (concentration required to inhibit protein synthesis by 50%, 10(-10)-2.5 x 10(-13) M). IT potentiation by both types of HSA-Mo conjugates, however, is inhibited by whole human serum. In contrast, human cerebrospinal fluid has no effect on the potentiation of IT by Mo or HSA-Mo conjugates. The serum blocking factors reside mostly in a Mr 40,000-90,000 protein fraction. Serum components of low molecular weight (less than 10,000) show no detectable effect upon the stability of HSA-Mo conjugates. The toxicity of HSA-SIA-Mo in vivo was investigated by intrathecal injections in rats. Concentrations of up to 60 micrograms/kg can be injected into the brain with only transient neurological sequelae. We therefore conclude that if the systemic delivery of HSA-Mo conjugates for the potentiation of ricin A chain-IT presents some limitations due to the blocking effect of serum, the application of HSA-Mo conjugates in combination with ricin A chain-IT for regional tumor therapy in the brain appears more promising.


Asunto(s)
Fenómenos Fisiológicos Sanguíneos , Supervivencia Celular/efectos de los fármacos , Líquido Cefalorraquídeo/fisiología , Inmunotoxinas/toxicidad , Monensina/farmacología , Ricina/toxicidad , Albúmina Sérica/farmacología , Cloruro de Amonio/farmacología , Animales , Línea Celular , Reactivos de Enlaces Cruzados , Disulfuros/metabolismo , Ditiotreitol/farmacología , Sinergismo Farmacológico , Humanos , Cinética , Monensina/toxicidad , Ratas , Albúmina Sérica/toxicidad , Succinimidas
19.
Chemosphere ; 161: 119-126, 2016 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-27424053

RESUMEN

Exposure of beneficial soil organisms to chemical mixtures is of great concern and can result in unexpected deleterious consequences. We investigated the effects of concurrent soil contamination with monensin, a veterinary pharmaceutical and feed additive, and copper, on earthworm copper uptake and reproductive success. The animals were exposed for 14 or 28 days to both substances and the results showed that the Cu body burden of earthworms increases in the presence of monensin. The harmful effects of Cu on earthworm cocoon production were considerably higher when monensin was also present in the soil. To localise the copper in earthworm tissues, histological staining was performed using two different dyes (rubeanic acid and 5-4-(p-dimethylaminobenzylidene)-rhodanine). Laser ablation inductively coupled plasma mass spectrometry (LA-ICP-MS) was used to quantify the Cu levels in the tissues. Cu was found predominantly in the gut wall. The Cu content in the body wall was at least ten times lower compared to the gut, but was proportional to the level of soil contamination. Concurrent soil contamination with monensin and copper resulted in higher earthworm Cu levels and in decreased reproductive success of these important soil decomposers.


Asunto(s)
Cobre/metabolismo , Monensina/toxicidad , Oligoquetos/fisiología , Contaminantes del Suelo/toxicidad , Drogas Veterinarias/toxicidad , Animales , Cobre/análisis , Monitoreo del Ambiente , Ionóforos/análisis , Oligoquetos/efectos de los fármacos , Reproducción/efectos de los fármacos , Suelo/química , Contaminantes del Suelo/análisis , Contaminantes del Suelo/metabolismo
20.
Biochim Biophys Acta ; 1031(2): 225-46, 1990 May 07.
Artículo en Inglés | MEDLINE | ID: mdl-2160275

RESUMEN

Monensin, a monovalent ion-selective ionophore, facilitates the transmembrane exchange of principally sodium ions for protons. The outer surface of the ionophore-ion complex is composed largely of nonpolar hydrocarbon, which imparts a high solubility to the complexes in nonpolar solvents. In biological systems, these complexes are freely soluble in the lipid components of membranes and, presumably, diffuse or shuttle through the membranes from one aqueous membrane interface to the other. The net effect for monensin is a trans-membrane exchange of sodium ions for protons. However, the interaction of an ionophore with biological membranes, and its ionophoric expression, is highly dependent on the biochemical configuration of the membrane itself. One apparent consequence of this exchange is the neutralization of acidic intracellular compartments such as the trans Golgi apparatus cisternae and associated elements, lysosomes, and certain endosomes. This is accompanied by a disruption of trans Golgi apparatus cisternae and of lysosome and acidic endosome function. At the same time, Golgi apparatus cisternae appear to swell, presumably due to osmotic uptake of water resulting from the inward movement of ions. Monensin effects on Golgi apparatus are observed in cells from a wide range of plant and animal species. The action of monensin is most often exerted on the trans half of the stacked cisternae, often near the point of exit of secretory vesicles at the trans face of the stacked cisternae, or, especially at low monensin concentrations or short exposure times, near the middle of the stacked cisternae. The effects of monensin are quite rapid in both animal and plant cells; i.e., changes in Golgi apparatus may be observed after only 2-5 min of exposure. It is implicit in these observations that the uptake of osmotically active cations is accompanied by a concomitant efflux of H+ and that a net influx of protons would be required to sustain the ionic exchange long enough to account for the swelling of cisternae observed in electron micrographs. In the Golgi apparatus, late processing events such as terminal glycosylation and proteolytic cleavages are most susceptible to inhibition by monensin. Yet, many incompletely processed molecules may still be secreted via yet poorly understood mechanisms that appear to bypass the Golgi apparatus. In endocytosis, monensin does not prevent internalization. However, intracellular degradation of internalized ligands may be prevented.(ABSTRACT TRUNCATED AT 400 WORDS)


Asunto(s)
Transporte Biológico/efectos de los fármacos , Aparato de Golgi/efectos de los fármacos , Monensina/farmacología , Animales , Endocitosis/efectos de los fármacos , Exocitosis/efectos de los fármacos , Humanos , Monensina/toxicidad , Potasio/metabolismo , Protones , Sodio/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA